SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Caleres Inc – ‘10-Q’ for 8/4/18 – ‘EX-10.1’

On:  Wednesday, 9/12/18, at 3:41pm ET   ·   For:  8/4/18   ·   Accession #:  14707-18-37   ·   File #:  1-02191

Previous ‘10-Q’:  ‘10-Q’ on 6/13/18 for 5/5/18   ·   Next:  ‘10-Q’ on 12/12/18 for 11/3/18   ·   Latest:  ‘10-Q’ on 12/5/23 for 10/28/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/12/18  Caleres Inc                       10-Q        8/04/18   84:13M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    915K 
 2: EX-10.1     Material Contract                                   HTML     87K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
12: R1          Document and Entity Information                     HTML     43K 
13: R2          Condensed Consolidated Balance Sheets               HTML    110K 
14: R3          Condensed Consolidated Statements of Earnings       HTML     71K 
15: R4          Condensed Consolidated Statements of Comprehensive  HTML     51K 
                Income                                                           
16: R5          Condensed Consolidated Statements of Cash Flows     HTML    108K 
17: R6          Basis of Presentation                               HTML     31K 
18: R7          Impact of New Accounting Pronouncements             HTML     43K 
19: R8          Acquisitions                                        HTML     62K 
20: R9          Revenues                                            HTML    175K 
21: R10         Earnings Per Share                                  HTML     65K 
22: R11         Restructuring and Other Initiatives                 HTML     34K 
23: R12         Business Segment Information                        HTML     79K 
24: R13         Inventories                                         HTML     37K 
25: R14         Goodwill and Intangible Assets                      HTML    110K 
26: R15         Shareholders' Equity                                HTML    148K 
27: R16         Share-Based Compensation                            HTML    152K 
28: R17         Retirement and Other Benefit Plans                  HTML     70K 
29: R18         Risk Management and Derivatives                     HTML     91K 
30: R19         Fair Value Measurements                             HTML    144K 
31: R20         Income Taxes                                        HTML     37K 
32: R21         Commitments and Contingencies                       HTML     37K 
33: R22         Financial Information for the Company and its       HTML    620K 
                Subsidiaries                                                     
34: R23         Acquisitions (Tables)                               HTML     48K 
35: R24         Revenues (Tables)                                   HTML    164K 
36: R25         Earnings Per Share (Tables)                         HTML     60K 
37: R26         Business Segment Information (Tables)               HTML     81K 
38: R27         Inventories (Tables)                                HTML     38K 
39: R28         Goodwill and Intangible Assets (Tables)             HTML    163K 
40: R29         Shareholders' Equity (Tables)                       HTML    149K 
41: R30         Share-Based Compensation (Tables)                   HTML    139K 
42: R31         Retirement and Other Benefit Plans (Tables)         HTML     68K 
43: R32         Risk Management and Derivatives (Tables)            HTML     91K 
44: R33         Fair Value Measurements (Tables)                    HTML    129K 
45: R34         Financial Information for the Company and its       HTML    619K 
                Subsidiaries (Tables)                                            
46: R35         Impact of New Accounting Pronouncements             HTML     51K 
                (Narrative) (Details)                                            
47: R36         Acquisitions (Narrative) (Details)                  HTML     71K 
48: R37         Acquisitions (Schedules of Allocation of Purchase   HTML     66K 
                Price) (Details)                                                 
49: R38         Revenues (Narrative) (Details)                      HTML     42K 
50: R39         Revenues (Schedule of Impact of the Adoption of     HTML     69K 
                Topic 606) (Details)                                             
51: R40         Revenues (Schedule of Disagreggation of Revenue)    HTML     56K 
                (Details)                                                        
52: R41         Revenues (Schedule of Contract Balances) (Details)  HTML     34K 
53: R42         Earnings Per Share (Narrative) (Details)            HTML     32K 
54: R43         Earnings Per Share (Schedule of Earnings Per        HTML     55K 
                Share, Basic and Diluted) (Details)                              
55: R44         Restructuring and Other Initiatives (Narrative)     HTML     43K 
                (Details)                                                        
56: R45         Business Segment Information (Schedule of Business  HTML     45K 
                Segment Information) (Details)                                   
57: R46         Business Segment Information (Schedule of           HTML     33K 
                Reconciliation of Operating Earnings Before Income               
                Taxes) (Details)                                                 
58: R47         Inventories (Schedule of Inventories) (Details)     HTML     36K 
59: R48         Goodwill and Intangible Assets (Narrative)          HTML     63K 
                (Details)                                                        
60: R49         Goodwill and Intangible Assets (Schedule of         HTML     44K 
                Goodwill and Intangible Assets) (Details)                        
61: R50         Goodwill and Intangible Assets (Schedule of Finite  HTML     57K 
                and Indefinite-Lived Intangible Assets) (Details)                
62: R51         Shareholders' Equity (Schedule of Changes in        HTML     74K 
                Shareholders' Equity and Noncontrolling Interests)               
                (Details)                                                        
63: R52         Shareholders' Equity (Schedule of Accumulated       HTML     65K 
                Other Comprehensive Loss) (Details)                              
64: R53         Share-Based Compensation (Narrative) (Details)      HTML     63K 
65: R54         Share-based Compensation (Schedule of Restricted    HTML     50K 
                Stock Activity) (Details)                                        
66: R55         Share-based Compensation (Schedule of Stock Option  HTML     54K 
                Activity) (Details)                                              
67: R56         Retirement and Other Benefit Plans (Shedule of Net  HTML     46K 
                Benefit Income) (Details)                                        
68: R57         Risk Management and Derivatives (Narrative)         HTML     29K 
                (Details)                                                        
69: R58         Risk Management and Derivatives (Schedule of        HTML     39K 
                Contract Notional Amount of All Purchase and Sale                
                Contracts of a Foreign Currency) (Details)                       
70: R59         Risk Management and Derivatives (Schedule of Fair   HTML     36K 
                Values of Derivative Instruments Designated as                   
                Hedging Instruments Included within the Condensed                
                Consolidated Balance Sheet) (Details)                            
71: R60         Risk Management and Derivatives (Schedule of        HTML     41K 
                Effect of Derivative Instruments in Cash Flow                    
                Hedging Relationships on the Condensed                           
                Consolidated Statements of Earnings) (Details)                   
72: R61         Fair Value Measurements (Narrative) (Details)       HTML     37K 
73: R62         Fair Value Measurements (Schedule of Assets and     HTML     62K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis) (Details)                                                 
74: R63         Fair Value Measurements (Schedule of Impairment     HTML     34K 
                Charges) (Details)                                               
75: R64         Fair Value Measurements (Schedule of Fair Value of  HTML     39K 
                Financial Instruments) (Details)                                 
76: R65         Income Taxes (Narrative) (Details)                  HTML     51K 
77: R66         Commitments and Contingencies (Narrative)           HTML     57K 
                (Details)                                                        
78: R67         Financial Information for the Company and its       HTML     33K 
                Subsidiaries (Narrative) (Details)                               
79: R68         Financial Information for the Company and its       HTML    142K 
                Subsidiaries (Schedule of Condensed Consolidating                
                Balance Sheet) (Details)                                         
80: R69         Financial Information for the Company and its       HTML    104K 
                Subsidiaries (Schedule of Condensed Consolidating                
                Statement of Comprehensive Income) (Details)                     
81: R70         Financial Information for the Company and its       HTML     82K 
                Subsidiaries (Schedule of Condensed Consolidating                
                Statement of Cash Flows) (Details)                               
83: XML         IDEA XML File -- Filing Summary                      XML    159K 
82: EXCEL       IDEA Workbook of Financial Reports                  XLSX    104K 
 6: EX-101.INS  XBRL Instance -- cal-20180804                        XML   5.16M 
 8: EX-101.CAL  XBRL Calculations -- cal-20180804_cal                XML    198K 
 9: EX-101.DEF  XBRL Definitions -- cal-20180804_def                 XML    736K 
10: EX-101.LAB  XBRL Labels -- cal-20180804_lab                      XML   1.48M 
11: EX-101.PRE  XBRL Presentations -- cal-20180804_pre               XML   1.02M 
 7: EX-101.SCH  XBRL Schema -- cal-20180804                          XSD    151K 
84: ZIP         XBRL Zipped Folder -- 0000014707-18-000037-xbrl      Zip    314K 


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 10.1

AMENDED AND RESTATED SEVERANCE AGREEMENT
This SEVERANCE AGREEMENT (the “Agreement”) is effective as of June 14, 2018 (“Effective Date”) by and between John W. Schmidt (“Employee”) and Caleres, Inc., a New York corporation (“Caleres” and, together with its subsidiaries, the “Company”).
WHEREAS, Employee and the Company previously entered into a Severance Agreement with an Effective Date of December 12, 2012 and Employee and Company now desire to amend and restate that agreement in its entirety as set herein; and
WHEREAS, Caleres is engaged, directly and indirectly through its subsidiaries, in the sourcing and retail and wholesale sale of footwear in the United States and throughout the world;
WHEREAS, Employee is employed by Caleres or a wholly-owned subsidiary of Caleres in an executive capacity, possesses intimate knowledge of the business and affairs of the Company, and has acquired, and will continue to acquire, certain confidential, proprietary and trade secret information and data with respect to the Company;
WHEREAS, Caleres desires to insure, insofar as possible, that the Company will continue to have the benefit of Employee’s services and to protect the confidential information and goodwill of the Company; and
WHEREAS, the Company recognizes that circumstances may arise in which a change in the control of Caleres occurs, through acquisition or otherwise, thereby causing uncertainty of employment without regard to Employee’s competence or past contributions which uncertainty may result in the loss of valuable services of Employee to the detriment of the Company and Caleres’s shareholders, and the Company and Employee wish to provide reasonable security to Employee against changes in Employee’s relationship with Caleres in the event of any such change in control; and
WHEREAS, both the Company and Employee are desirous that a proposal for any change of control or acquisition will be considered by Employee objectively and with reference only to the business interests of the Company and Caleres’s shareholders; and
WHEREAS, Employee will be in a better position to consider the best interests of the Company if Employee is afforded reasonable security, as provided in this Agreement, against altered conditions of employment which could result from any such change in control or acquisition.
NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements hereinafter set forth, the parties hereto mutually covenant and agree as follows:
Section 1.
Definitions

1.1“Board” means the Board of Directors of Caleres.






1.2“Business Unit” means any direct or indirect subsidiary, operating division or business unit of Caleres.

1.3“Cause” means (i) engaging by Employee in willful misconduct which is materially injurious to the Company; (ii) conviction of Employee of a felony; (iii) engaging by Employee in fraud, material dishonesty or gross misconduct in connection with the business of the Company; (iv) engaging by Employee in any act of moral turpitude reasonably likely to materially and adversely affect the Company or its business; (v) engaging by Employee in the illegal use of a controlled substance or using prescription medications unlawfully; or (vi) abuse by Employee of alcohol.

1.4“Change of Control” means the occurrence of any of the following events after the Effective Date:

(a)The acquisition by any Person of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (x) the then outstanding shares of common stock of Caleres (the “Outstanding Company Common Stock”) or (y) the combined voting power of the then outstanding voting securities of Caleres entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this paragraph (a) the following acquisitions shall not constitute a Change of Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (iv) any acquisition by any corporation pursuant to a transaction which complies with the exception set forth in paragraph (c) below; or

(b)Individuals who, as of the Effective Date of this Agreement, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or

(c)Consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets of another corporation (a “Business Combination”), in each case, unless, following such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 65% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Business Combination (including, without limitation, a corporation which as a result of such transaction owns the Company





or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be; or

(d)Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.

1.5"Code" means the Internal Revenue Code of 1986, as amended.

1.6"Competitor" means any Person which (a) in its prior fiscal year had annual gross sales volume or revenues of more than $20,000,000 attributable to the sale of footwear or (b) is reasonably expected to have such level of footwear sales or revenues in either the current fiscal year or the next following fiscal year.

1.7"Confidential Information" shall have the meaning set for in Section 10.

1.8"Customer" means any wholesale customer of Caleres and/or any Business Unit which either purchased from Caleres and/or any Business Unit during the one (1) year immediately preceding the Termination Date, or is reasonably expected by Caleres and/or any Business Unit to purchase from Caleres and/or any Business Unit in the one (1) year period immediately following the Termination Date, more than $1,000,000 in footwear.

1.9"ERISA" means the Employee Retirement Income Security Act of 1974, as amended.

1.10"Good Reason," when used with reference to a voluntary termination by Employee of Employee’s employment with the Company, means (i) a reduction in Employee’s base salary as in effect on the date hereof, or as the same may be increased from time to time; (ii) a reduction in Employee’s status, position, responsibilities or duties; (iii) the required relocation of Employee’s principal place of business, without Employee’s consent, to a location which is more than fifty (50) miles from Employee’s principal place of business on the Effective Date, or from such location to which Employee may transfer with Employee’s consent after the Effective Date; (iv) a material increase in the amount of time Employee is required to travel on behalf of the Company; (v) the failure of any successor of Caleres to assume this Agreement, or (vi) a material breach of this Agreement by the Company.

1.11"Person" means any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).

1.12"Termination Date" means the effective date as provided in this Agreement of the termination of Employee’s employment with the Company. Employee will have a termination of employment only if he has a separation from service determined based on all of the facts and circumstances and in accordance with the rules and regulations issued by the Treasury Department under Code Section 409A.





Section 2.    Term

2.1    Subject to Section 2.2, the term of this Agreement (the “Term”) shall be a period commencing on the Effective Date and ending on the first anniversary thereof.

2.2    The Term shall be automatically extended for successive one (1) year periods unless either party to this Agreement provides the other party with notice of termination at least ninety (90) days prior to the expiration of the original period or any one-year period thereafter.

Section 3.    Termination of Employment

3.1    The Company may terminate Employee’s employment at any time for Cause, effective upon written notice to Employee specifying in reasonable detail the particulars of Employee’s conduct deemed by the Company and/or such subsidiary to justify such termination for Cause.

3.2    The Company may terminate Employee’s employment without Cause at any time, effective upon written notice to Employee of termination specifying that such termination is without Cause.

3.3    Employee may terminate Employee’s employment with the Company at any time, with or without Good Reason.

Section 4.     Separation Benefits

4.1    If Employee’s employment is terminated by the Company for any reason other than for Cause, death or disability and Section 4.2 does not apply, Employee shall be entitled to the following separation benefits:

(a)    The Company shall pay, or cause to be paid, to Employee within 30 days of the Termination Date (i) the full base salary earned by Employee through, but unpaid at, the Termination Date, plus (ii) credit for any vacation earned by Employee but not used at the Termination Date, plus (iii) all other amounts owed by the Company to Employee (other than any bonus payment of any kind) but unpaid as of the Termination Date.

(b)    The Company shall pay, or cause to be paid, to Employee (i) in a lump sum not later than thirty (30) days after the Termination Date an amount equal to 200% of the sum of (A) Employee’s base annual salary at the highest rate in effect at any time during the twelve (12) months immediately preceding the Termination Date, and (B) Employee’s targeted bonus for the current year, and (ii) Employee’s bonus for the year of termination prorated to the Termination Date, paid at the time such bonus would have been paid if Employee had remained employed to the date of payment and calculated based on achievement of the applicable performance criteria applicable to such bonus payment.






(c)    The Company shall provide to Employee for a period of eighteen (18) months after the Termination Date medical and/or dental coverage under the Company’s medical and/or dental plans, without any cost to Employee in excess of any employee contribution that would be payable by Employee if Employee remained employed by a member of the Company; provided, however, that if Employee becomes employed with another employer during such eighteen (18)-month period and is eligible to receive medical and/or dental coverage under another employer-provided plan, the medical and/or dental coverage described herein shall be secondary to those provided under such other plan. In addition, on the last day of such eighteen (18)-month period, the Company shall pay, or cause to be paid, to Employee an amount in cash equal to the aggregate amount that would be payable by the Company for such medical and/or dental coverage for six (6) months if Employee remained employed by the Company for such period.

(d)    The restrictions applicable to each share of non-vested restricted stock of Caleres held by Employee that would have vested within the two (2) year period following the Termination Date had Employee remained employed by the Company shall lapse as of the Termination Date.

(e)    Each non-vested option to purchase Caleres stock held by Employee that would have vested within the two (2) year period following the Termination Date had Employee remained employed by the Company shall vest as of the Termination Date.

(f)    The Company shall pay the reasonable costs of outplacement services selected by the Company for a reasonable period of time following the Termination Date; provided, however, that no such outplacement services shall be provided after the last day of the second calendar year following the calendar year in which the Termination Date occurs.

4.2    If Employee’s employment is terminated within twenty-four (24) months after a Change of Control (x) by the Company for any reason other than for Cause, death or disability, or (y) by Employee within ninety (90) days after the occurrence of Good Reason, Employee shall be entitled to the following separation benefits in place of, and not in addition to, the benefits set forth in Section 4.1:

(a)    The Company shall pay, or cause to be paid, to Employee within 30 days of the Termination Date (i) the full base salary earned by Employee through, but unpaid at, the Termination Date, plus (ii) credit for any vacation earned by Employee but not taken at the Termination Date, plus (iii) all other amounts owed by the Company to Employee (other than any bonus payment of any kind) but unpaid as of the Termination Date.

(b)    The Company shall pay, or cause to be paid, to Employee (i) in a lump sum six (6) months after the Termination Date an amount equal to 300% of the sum of (A) Employee’s base annual salary at the highest rate in effect at any time during the twelve (12) months immediately preceding the Termination Date, and (B) Employee’s targeted bonus for the current year; and (ii) Employee’s targeted bonus payment for the year of termination prorated to the Termination Date.






(c)    The Company shall provide to Employee for a period of eighteen (18) months after the Termination Date medical and/or dental coverage under the Company’s medical and dental plans, without any cost to Employee in excess of any employee contribution that would be payable by Employee if Employee remained employed by the Company; provided, however, that if Employee becomes employed with another employer during such eighteen (18)-month period and is eligible to receive medical and/or dental coverage under another employer-provided plan, the medical and/or dental coverage described herein shall be secondary to those provided under such other plan. In addition, on the last day of such eighteen (18)-month period, the Company shall pay, or cause to be paid, to Employee an amount in cash equal to the aggregate amount that would be payable by the Company for such medical and/or dental coverage for six (6) months if Employee remained employed by the Company for such period.

(d)    The restrictions applicable to each share of non-vested restricted stock of Caleres held by Employee shall lapse and be exercisable as of the Termination Date.

(e)    Each non-vested option to purchase Caleres stock held by Employee shall vest and be exercisable as of the Termination Date.

(f)    For purposes of determining Employee’s benefit under the Company’s Supplemental Employment Retirement Plan, an additional two (2) years of Credited Service shall be credited to Employee’s actual or deemed Credited Service.

(g)    The Company shall pay the reasonable costs of outplacement services selected by the Company for a reasonable period of time following the Termination Date; provided, however, that no such outplacement services shall be provided after the last day of the second calendar year following the calendar year in which the Termination Date occurs.

4.3    If Employee’s employment is terminated for any reason other than such reasons specified in Sections 4.1 and 4.2, the Company shall pay, or cause to be paid, to Employee within 30 days of the Termination Date (i) the full base salary earned by Employee through, but unpaid at, the Termination Date, plus (ii) credit for any vacation earned by Employee but not taken at the Termination Date, plus (iii) all other amounts owed by the Company to Employee (other than any bonus payment of any kind) but unpaid as of the Termination Date.

4.4    The benefits set forth in Sections 4.1(c) and 4.2(c) shall run concurrently with any period of continuation coverage to which Employee is entitled under Section 601 of ERISA. Upon Employee’s re-employment during the period specified in each such Section, to the extent covered by the new employer’s plan, coverage under the Company’s plan shall lapse, subject to any continuation of coverage rights under Section 601 of ERISA. Employee’s participation in and/or coverage under all other employee benefit plans, programs or arrangements sponsored or maintained by the Company shall cease effective as of the Termination Date except as otherwise provided in such employee benefit plan, program or arrangement.






Section 5.    Mitigation or Reduction of Benefits

Employee shall not be required to mitigate the amount of any payment provided for in Section 4 by seeking other employment or otherwise. Except as otherwise specifically set forth herein, the amount of any payment or benefits provided in Section 4 shall not be reduced by any compensation or benefits or other amounts paid to or earned by Employee as the result of employment by another employer after the Termination Date or otherwise.

Section 6.    Employee Expenses After Change in Control

If Employee’s employment is terminated by the Company within twenty-four (24) months after a Change in Control and there is a dispute with respect to this Agreement, then all Employee’s costs and expenses (including reasonable legal and accounting fees) incurred by Employee (a) to defend the validity of this Agreement, (b) to contest any termination for Cause, (c) to contest any determinations by the Company concerning the amounts payable by or on behalf of the Company under this Agreement, or (d) to otherwise obtain or enforce any right or benefit provided to Employee by this Agreement, shall be paid by the Company. The Company shall make payment of such reimbursements from time to time, but in no event later than the last day of the calendar year following the calendar year in which such expenses are incurred, provided Employee timely submits reasonable documentation of such expenses. In the event Employee is not the prevailing party in any such contest, Employee shall pay back any reimbursements made by the Company hereunder within 30 days of final disposition of such contest.

Section 7.    Release

Notwithstanding anything to the contrary stated in this Agreement, no benefits will be paid pursuant to Section 4 except under Section 4.1(a), 4.2(a) or 4.3 prior to execution by Employee of a release of the Company substantially in the form attached as Exhibit A, with such changes as may be made by the Company in its sole discretion in order to comply with and stay current with applicable laws and regulations. Unless Employee executes such release and returns it to the Company within 45 days of his Termination Date, all benefits except under Sections 4.1(a), 4.2(a) or 4.3 shall be forfeited.






Section 8.    Excise Tax

In the event that a payment or benefit under this Agreement would result in the application of an excise tax under Code Section 4999, the cash severance payment described in Section 4.2 shall be reduced so that the total parachute payments received by the Employee equal the better after-tax amount of either: the full amount of such payments otherwise determined under the Agreement and any other plan or agreement which provides parachute payments to the Employee, subject to the excise tax under Code Section 4999; or 2.99 times the Participant’s “base amount” as defined in Code Section 280G and the regulations thereunder.

Section 9.    Covenant Not to Compete

9.1    During Employee’s employment with Caleres and/or any Business Unit and for a period of two (2) years after the Termination Date (collectively the “Restricted Period”), Employee will not, directly or indirectly, on Employee’s own behalf or on behalf of any other Person (whether as owner, partner, consultant, employee or otherwise):

(a)    provide any executive, managerial, supervisory, and/or consulting services with respect to the footwear industry and/or the footwear business in the United States for any Competitor;

(b)    hold any executive, managerial and/or supervisory position with any Competitor in the United States;

(c)    assist any Competitor in competing against Caleres and/or any Business Unit for which Employee performs or performed substantial work and/or has or had access to Confidential Information (each a “Relevant Business Unit”) (i) in the United States and/or (ii) in any other country in which Caleres and/or any Relevant Business Unit is doing business in the one year immediately preceding the Termination Date (each a “Foreign Country”) if Employee had access to Confidential Information regarding the Company’s business in such Foreign Country;

(d)    engage in any research, development and/or planning activities or efforts for a Competitor, whether as an employee, consultant, independent contractor or otherwise, to assist the Competitor in competing (i) in the footwear industry in the United States or (ii) in any Foreign Country if Employee had access to Confidential Information regarding the Company’s business in such Foreign Country;

(e)    cause or attempt to cause any Customer to divert, terminate, limit, modify or fail to enter into any existing or potential relationship with Caleres and/or any Relevant Business Unit;

(f)    assist any Competitor in connection with any plan, effort, activity or undertaking to cause or attempt to cause any Customer to divert, terminate, limit, modify or fail to enter into any existing or potential relationship with Caleres and/or any Relevant Business Unit;






(g)    cause or attempt to cause any footwear supplier or manufacturer of Caleres and/or any Relevant Business Unit to divert, terminate, limit, modify or fail to enter into any existing or potential relationship with Caleres and/or any Relevant Business Unit;

(h)    assist any Competitor in connection with any plan, effort, activity or undertaking to cause or attempt to cause any footwear supplier or manufacturer of Caleres and/or any Relevant Business Unit to divert, terminate, limit, modify or fail to enter into any existing or potential relationship with Caleres and/or any Relevant Business Unit; and/or

(i)    solicit, entice, employ or seek to employ, in the footwear industry, any executive, managerial and/or supervisory employee of, or any consultant or advisor to, Caleres and/or any Relevant Business Unit.

9.2    Employee recognizes and agrees that the restraints contained in Section 9.1 are reasonable and should be fully enforceable in view of, among other things, the high level positions Employee has had with Caleres and/or any Relevant Business Unit(s), the national and international nature of both the Company’s collective business and competition in the footwear industry, and the legitimate interests of the Company in protecting its confidential, proprietary and trade secret information (“Confidential Information”) and their respective customer goodwill and relationships. Employee specifically hereby acknowledges and confirms that Employee is willing and intends to, and will, abide fully by the terms of Section 9.1. Employee further agrees that the Company would not have adequate protection if Employee were permitted to work for its competitors in violation of the terms of this Agreement since the Company would, among other things, be unable to verify whether (i) its Confidential Information was being disclosed and/or misused, and/or (ii) Employee was involved in diverting or helping to divert the Company’s customers and/or customer goodwill.

9.3    Employee agrees to disclose, during the Restricted Period, the terms of this Section 9 to any potential future employer.

Section 10.    Confidential Information

10.1    Employee acknowledges and agrees that during Employee’s employment, Employee has been and/or will be provided and have access to certain Confidential Information of the Company. Employee agrees to keep secret and confidential, and not to use or disclose to any third-parties, except as directly required for Employee to perform Employee's employment responsibilities for the Company, any of the Company’s Confidential Information.

10.2    Confidential Information includes all confidential and/or trade secret information of the Company (regardless of the form or medium in which it may exist or be stored or preserved) and includes, but is not limited to, all such information containing or reflecting any:

(a)    lists or other identification of customers or prospective customers of Caleres and/or any Relevant Business Unit (and/or key individuals employed or engaged by such parties);






(b)    lists or other identification of sources or prospective sources of Caleres’s and/or any Relevant Business Unit’s products or components thereof (and/or key individuals employed or engaged by such parties);

(c)    compilations, information, designs, drawings, files, formulae, lists, machines, maps, methods, models, notes or other writings, plans, records, regulatory compliance procedures, reports, specialized or technical data, schematics, source code, object code, documentation, and software relating to the development, manufacture, fabrication, assembly, marketing and/or sale of Caleres’s and/or any Relevant Business Unit’s products;

(d)    financial, distribution, sales and marketing information, data, plans, and/or strategies of Caleres and/or any Relevant Business Unit;

(e)    equipment, materials, procedures, processes, and techniques used in, or related to, the development, manufacture, assembly, fabrication or other production and quality control of the Caleres’s and/or any Relevant Business Unit’s products and services;

(f)    Caleres’s and/or any Relevant Business Unit’s relations and/or dealings with its customers, prospective customers, suppliers and prospective suppliers and the nature and type of products or services rendered to such customers (or proposed to be rendered to prospective customers);

(g)    Caleres’s and/or any Relevant Business Unit’s relations with its employees (including, without limitation, salaries, job classifications and skill levels); and

(h)    any other information designated by Caleres and/or any Relevant Business Unit to be confidential, secret and/or proprietary (including without limitation, information provided by customers or suppliers of Caleres and/or any Relevant Business Unit).

Notwithstanding the foregoing, the term “Confidential Information” shall not consist of any data or other information which has been made publicly available or otherwise placed in the public domain other than by Employee in violation of this Agreement.

10.3    Employee will not, directly or indirectly, copy, reproduce or otherwise duplicate, record, abstract, summarize or otherwise use for Employee or use for, or disclose to, any party other than Caleres, or any subsidiary or affiliate of Caleres, any Confidential Information, without Caleres’s prior written permission or except as required for the proper performance of Employee’s duties on behalf of the Company.

10.4    Employee understands that Confidential Information may or may not be labeled as “confidential” and will treat all information as confidential unless otherwise informed by Caleres.

10.5    At the termination of Employee’s employment with the Company or at any other time Caleres or any subsidiary or affiliate thereof may request, Employee shall promptly deliver to Caleres all documents and other materials, whether in physical or electronic form (including all copies thereof), containing any Confidential Information.






Section 11.    Injunctive Relief

In the event of a breach or threatened breach of any of Employee’s duties or obligations under the terms and provisions of Section 9, Section 10, Section 12.2 or Section 12.9, the Company shall be entitled, in addition to any other legal or equitable remedies it may have in connection therewith (including any right to damages that it may suffer), to temporary, preliminary and permanent injunctive relief restraining such breach or threatened breach. Employee hereby expressly acknowledges that the harm that might result to the Company’s business as a result of noncompliance by Employee with any of the provisions of Section 9, Section 10, Section 12.2 or Section 12.9 would be largely irreparable. Employee specifically agrees that if there is a question as to the enforceability of any of the provisions of Section 9, Section 10, Section 12.2 or Section 12.9, Employee will not engage in any conduct inconsistent with or contrary to such Sections until after the question has been resolved by a final judgment of a court of competent jurisdiction. Employee undertakes and agrees that if Employee breaches or threatens to breach the Agreement, Employee shall be liable for any attorneys’ fees and costs incurred by the Company in enforcing its rights hereunder.

Section 12.    Miscellaneous

12.1    Notice. All notices hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered personally or by courier, or (b) when received by facsimile (including electronic mail), receipt confirmed, or (c) on the third business day following the mailing thereof by registered or certified mail, postage prepaid, or (d) on the first business day following the mailing thereof by overnight delivery service, in each case addressed as set forth below:
If to the Company:
Caleres, Inc.
8300 Maryland Avenue
St. Louis, Missouri 63166-0029
Attention: General Counsel
If to Employee:
John W. Schmidt
200 West 67th Street Apt. 321
New York, New York 10023

Any party may change the address to which notices are to be addressed by giving the other party written notice in the manner herein set forth.

12.2    Successors; Binding Agreement.

(a)    Caleres shall require any successor to all or substantially all of the business and/or assets of the Company (whether such succession is direct or indirect, by purchase, merger, consolidation or otherwise), prior to or upon such succession, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would have





been required to perform it if no such succession had taken place. To the extent such transaction constitutes a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company under Code Section 409A and the rules and regulations thereunder, failure of Caleres to obtain such agreement upon or prior to the effectiveness of any such succession shall be a material breach of this Agreement and shall entitle Employee to benefits from the Company in the same amounts and on the same terms as Employee would be entitled hereunder if Employee’s employment was terminated without Cause within twenty-four (24) months after a Change of Control. For purposes of the preceding sentence, the date on which any such succession becomes effective shall be deemed the Termination Date.

(b)    Caleres shall also have the right, but not the obligation, to assign this Agreement, without Employee’s consent, to any successor to all or substantially all of the business and/or assets of a Business Unit for which Employee performs substantially all of Employee’s duties (whether such succession is direct or indirect, by purchase, merger, consolidation or otherwise). In the event, and only in the event, Caleres elects to assign this Agreement to such successor of a Business Unit, a Change of Control will be deemed to have occurred and Caleres shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such succession had taken place. No Change of Control shall be deemed to have occurred if Caleres does not elect to assign this Agreement to such successor of a Business Unit.

(c)    This Agreement is personal to Employee and Employee may not assign or delegate any part of Employee’s rights or duties hereunder to any other person, except that this Agreement shall inure to the benefit of and be enforceable by Employee’s legal representatives, executors, administrators, heirs and beneficiaries.

12.3    Judicial Modification. If and to the extent that any Section, term and/or provision of this Agreement is determined by a court of competent jurisdiction to be unenforceable under applicable law, then such Section(s), term(s) and/or provision(s) shall not be void but instead shall be modified and, to the maximum extent permissible under applicable law, enforced.

12.4    Headings. The headings in this Agreement are inserted for convenience of reference only and shall not in any way affect the meaning or interpretation of this Agreement.

12.5    Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.

12.6    Waiver. Neither any course of dealing nor any failure or neglect of either party hereto in any instance to exercise any right, power or privilege hereunder or under law shall constitute a waiver of such right, power or privilege or of any other right, power or privilege or of the same right, power or privilege in any other instance. Without limiting the generality of the foregoing, Employee’s continued employment without objection shall not constitute Employee’s consent to, or a waiver of Employee’s rights with respect to, any circumstances constituting Good





Reason. All waivers by either party hereto must be contained in a written instrument signed by the party to be charged therewith, and, in the case of the Company, by its duly authorized officer.

12.7    Entire Agreement. This instrument constitutes the entire agreement of the parties in this matter and shall supersede any other agreement between the parties, oral or written, concerning the same subject matter.

12.8    Amendment. Subject to Section 12.3, no modification, amendment or waiver of any of the provisions of this Agreement shall be effective unless in writing specifically referring hereto, and signed by the parties hereto.

12.9    Governing Law. In light of Company’s and Employee’s substantial contacts with the State of Missouri, the facts that the Company is headquartered in Missouri and Employee resides in and/or reports to Company management in Missouri, the parties’ interests in ensuring that disputes regarding the interpretation, validity and enforceability of this Agreement are resolved on a uniform basis, and Caleres’s execution of, and the making of, this Agreement in Missouri, the parties agree that: (i) any litigation involving any noncompliance with or breach of the Agreement, or regarding the interpretation, validity and/or enforceability of the Agreement, shall be filed and conducted exclusively in the state courts in St. Louis County, Missouri, or the U.S. District Court for the Eastern District of Missouri; and (ii) this Agreement shall be interpreted in accordance with and governed by the laws of the State of Missouri, without regard for any conflict of law principles. Employee agrees that Employee under no circumstances will, either alone or in conjunction with anyone else, file or pursue any such litigation other than in such state or federal courts in Missouri, and Employee hereby consents and agrees that any such litigation filed in any other court(s) shall be dismissed and that Employee may be enjoined from filing and/or pursuing any such action.

12.10    Third Party Beneficiaries. Employee agrees that Caleres’s subsidiaries are third party beneficiaries of this Agreement and hereby consents to the enforcement by any subsidiary of Caleres of the provisions contained herein, including without limitation, the provisions of Section 9 and Section 10.

12.11    409A Interpretation. With respect to those amounts payable hereunder which are subject to Code Section 409A, this Agreement shall be interpreted in a manner so as to be consistent with such provision and the rules and regulations promulgated thereunder. The Company may modify the Agreement to the extent necessary to prevent a benefit or payment from being subject to a tax due to noncompliance with Code Section 409A. Notwithstanding anything herein to the contrary, in the event that Executive is determined to be a specified employee within the meaning of Code Section 409A, for purposes of any payment on termination of employment hereunder, payment(s) shall be made or begin, as applicable, on the first payroll date which is more than six months following the date of separation from service, to the extent required to avoid any adverse tax consequences under Code Section 409A.







IN WITNESS WHEREOF, Employee and Caleres have executed this Agreement as of the day and year first above written.

CALERES, INC.
 
EMPLOYEE
By:
 
Name:
 
Title:
Senior Vice President and Chief Human Resources Officer
 
 
Date:
 
Date:




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:9/12/184
For Period end:8/4/18
6/15/18
6/14/184
12/12/12
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/02/24  Caleres Inc.                      10-K        2/03/24  114:18M
 3/28/23  Caleres Inc.                      10-K        1/28/23  112:19M
 3/28/22  Caleres Inc.                      10-K        1/29/22  111:19M
 3/30/21  Caleres Inc.                      10-K        1/30/21  119:20M
Top
Filing Submission 0000014707-18-000037   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:24:06.2am ET